Oxidative stress in keratoconus?

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 12, 2011, Pages 8592-8597

  Arnal, Emma ^a   Peris Martínez, Cristina ^a,b   Menezo, Jose Luis ^a   Johnsen Soriano, Siv ^a   Romero, Francisco Javier ^a,c  

^a Fundación Oftalmológica Del Mediterráneo FOM   (Spain)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^c UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; GLUTATHIONE; MALONALDEHYDE; NITRITE; 4-HYDROXY-2-NONENAL; ALDEHYDE; ANTIOXIDANT; BIOLOGICAL MARKER;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOCONUS; KERATOMILEUSIS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; LESIONS AND DEFECTS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ALDEHYDES; ANTIOXIDANTS; BIOLOGICAL MARKERS; DILATATION, PATHOLOGIC; FEMALE; GLUTATHIONE; HUMANS; KERATOCONUS; KERATOMILEUSIS, LASER IN SITU; LIPID PEROXIDATION; MALE; MIDDLE AGED; NITRITES; OXIDATIVE STRESS;

EID: 84855387074     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7732     Document Type: Article

References (48)

1. Rabinowitz YS. Keratoconus. Surv Ophthalmol. 1998;42:297-319.
2. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol. 1984; 28:293-322.
3. Seiler T, Quurke AW. Iatrogenic keratectasia after lasik in a case of forme fruste keratoconus. J Cataract Refract Surg. 1998;24:1007-1009.
4. Gondhowiardjo TD, van Haeringen NJ, Volker-Dieben HJ, et al. Analysis of corneal aldehyde dehydrogenase patterns in pathologic corneas. Cornea. 1993;12:146-154.
5. Gondhowiardjo TD, van Haeringen NJ. Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione s-transferase in pathologic corneas. Cornea. 1993;12:310-314.
6. Kenney MC, Brown DJ, Rajeev B. Everett Kinsey lecture. The elusive causes of keratoconus: a working hypothesis. Clao J. 2000; 26:10-13.
7. Behndig A, Karlsson K, Johansson BO, Brannstrom T, Marklund SL. Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci. 2001;42:2293-2296.
8. Buddi R, Lin B, Atilano SR, et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem. 2002;50:341-351.
9. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 1991;11:81-128.
10. Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med. 1998;25:392-403.
11. Szabo C, Ohshima H. DNA damage induced by peroxynitrite: subsequent biological effects. Nitric Oxide. 1997;1:373-385.
12. Murphy MP, Packer MA, Scarlett JL, Martin SW. Peroxynitrite: a biologically significant oxidant. Gen Pharmacol. 1998;31:179-186.
13. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci. 1990;15:129-135.
14. Hashimoto M, Sibata T, Wasada H, Toyokuni S, Uchida K. Structural basis of protein-bound endogenous aldehydes. Chemical and immunochemical characterizations of configurational isomers of a 4-hydroxy-2-nonenal-histidine adduct. J Biol Chem. 2003;278: 5044-5051.
15. Zhou L, Sawaguchi S, Twining SS, et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci. 1998;39:1117-1124.
16. Rosenfeld ME, Palinski W, Yla-Herttuala S, Butler S, Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein b in atherosclerotic lesions of varying severity from whhl rabbits. Arteriosclerosis. 1990;10:336-349.
17. Traverso N, Menini S, Odetti P, et al. Lipoperoxidation in hepatic subcellular compartments of diabetic rats. Free Radic Biol Med. 1999;26:538-547.
18. Mattson MP. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 1998;21:53-57.
19. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. Amyloid-beta peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci. 1997;17:1046-1054.
20. Blanc EM, Kelly JF, Mark RJ, Waeg G, Mattson MP. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on g alpha(q/11). J Neurochem. 1997;69:570-580.
21. Bosch-Morell F, Flohé L, Marín N, Romero FJ. 4-Hydroxynonenal inhibits glutathione peroxidase: protection by glutathione. Free Radic Biol Med. 1999;26:1383-1387.
22. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502-522.
23. Arnal E, Miranda M, Barcia J, Bosch-Morell F, Romero FJ. Lutein and docosahexaenoic acid prevent cortex lipid peroxidation in streptozotocin-induced diabetic rat cerebral cortex. Neuroscience. 2009;166:271-278.
24. Arnal E, Miranda M, Johnsen-Soriano S, et al. Beneficial effect of docosahexanoic acid and lutein on retinal structural, metabolic, and functional abnormalities in diabetic rats. Curr Eye Res. 2009; 34:928-938.
25. Saleh D, Barnes PJ, Giaid A. Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155:1763-1769.
26. Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991;91:14S-22S.
27. Paradis V, Kollinger M, Fabre M, et al. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology. 1997;26:135-142.
28. Yoshino H, Hattori N, Urabe T, et al. Postischemic accumulation of lipid peroxidation products in the rat brain: immunohistochemical detection of 4-hydroxy-2-nonenal modified proteins. Brain Res. 1997;767:81-86.
29. Ohhira M, Ohtake T, Matsumoto A, et al. Immunohistochemical detection of 4-hydroxy-2-nonenal-modified-protein adducts in human alcoholic liver diseases. Alcohol Clin Exp Res. 1998;22:145S-149S.
30. Pedersen WA, Fu W, Keller JN, et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol. 1998;44:819-824.
31. Cross AH, Manning PT, Stern MK, Misko TP. Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J Neuroimmunol. 1997;80:121-130.
32. Dighiero P, Behar-Cohen F, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokines stimulation. Invest Ophthalmol Vis Sci. 1997;38:2045-2052.
33. McMenamin PG, Crewe JM. Cellular localisation and dynamics of nitric oxide synthase expression in the rat anterior segment during endotoxin-induced uveitis. Exp Eye Res. 1997;65:157-164.
34. Becquet F, Courtois Y, Goureau O. Nitric oxide in the eye: multifaceted roles and diverse outcomes. Surv Ophthalmol. 1997;42:71-82.
35. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol. 1996;9:836-844.
36. Kooy NW, Royall JA, Ischiropoulos H. Oxidation of 2',7'-dichlorofluorescin by peroxynitrite. Free Radic Res. 1997;27:245-254.
37. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med. 1995;151:1250-1254.
38. Porasuphatana S, Tsai P, Rosen GM. The generation of free radicals by nitric oxide synthase. Comp Biochem Physiol C Toxicol Pharmacol. 2003;134:281-289.
39. Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene. 2003;22:5734-5754.
40. Yanagiya N, Akiba J, Kado M, et al. Transient corneal edema induced by nitric oxide synthase inhibition. Nitric Oxide. 1997;1: 397-403.
41. Pappa A, Sophos NA, Vasiliou V. Corneal and stomach expression of aldehyde dehydrogenases: from fish to mammals. Chem Biol Interact. 2001;130-132:181-191.
42. Udar N, Atilano SR, Brown DJ, et al. SOD1: a candidate gene for keratoconus. Invest Ophthalmol Vis Sci. 2006;47:3345-3351.
43. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J Neurosci. 1997;17:5089-5100.
44. Twa MD, Nichols JJ, Joslin CE, et al. Characteristics of corneal ectasia after LASIK for myopia. Cornea. 2004;23:447-457.
45. Tuli SS, Iyer S. Delayed ectasia following LASIK with no risk factors: is a 300-um stromal bed enough?. J Refract Surg. 2007;23: 620-622.
46. Randleman JB, Russell B, Ward MA, Thompson KP, Stulting RD. Risk factors and prognosis for corneal ectasia after LASIK. Ophthalmology. 2003;110:267-275.
47. Randleman JB, Woodward M, Lynn ML, Stulting RD. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology. 2008;115:37-50.
48. Kim WJ, Rabinowitz YS, Meisler DM, Wilson SE. Keratocyte apoptosis associated with keratoconus. Exp Eye Res. 1999;69:475-481.